Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donafenib plus S-1 in Metastatic Pancreatic Cancer
NCT05138159Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donafenib, sponsored by Fudan University. Status: unknown.
02
Drugs
donafenib
Beyond the preview
Go deeper on NCT05138159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05138159.